Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Al-Rubaye (London, United Kingdom), K. Chauhan (London, United Kingdom), M. Arzim (London, United Kingdom), V. Osman (London, United Kingdom), E. Baker (London, United Kingdom), F. Henry (London, United Kingdom), R. Sachelle (London, United Kingdom), D. Burrage (London, United Kingdom). The acute effect of inhaled salbutamol and ipratropium on aortic stiffness and pressure wave reflection. 4408

Member's Comments

No comment yet.

Related content which might interest you: The acute effect of inhaled salbutamol and ipratropium on microvascular function Source: International Congress 2018 – Basic pharmacology Year: 2018 Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Source: Eur Respir J 2003; 21: 86-94 Year: 2003 Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD Source: Eur Respir J 2001; 18: Suppl. 33, 253s Year: 2001 Doppler echocardiographic assessment of the effects of inhaled LABAs on pulmonary artery pressure (PAP) in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 435s Year: 2006 Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Effect of inhaled fenoterol on the response to inspiratory threshold loading Source: Eur Respir J 2001; 18: Suppl. 33, 86s Year: 2001 Effects of inhaled salbutamol in primary pulmonary hypertension Source: Eur Respir J 2002; 20: 524-528 Year: 2002 Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001 Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline Source: Eur Respir J 2002; 19: 865-871 Year: 2002 Evaluation of the acute bronchodilator effect of beclomethasone/formoterol fixed combination on central and peripheral airway dimensions in asthmatic patients Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol Source: Eur Respir J 2001; 17: 368-373 Year: 2001 Effects of salmeterol, formoterol and placebo on pulmonary function and symptom recovery after histamine provocation in mild asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 710s Year: 2004 Effect of sequential nebulised salbutamol therapy on peak expiratory flow rate Source: Eur Respir J 2005; 26: Suppl. 49, 507s Year: 2005 Prolonged bronchodilation following deep inspiration predicts reversibility to salbutamol in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 373s Year: 2005 Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension Source: Eur Respir J 2001; 17: 14-19 Year: 2001 Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Does the inhalation device affect the bronchodilatory dose response curve of Salbutamol in asthma- and COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 473s Year: 2003 Pharmacokinetic differences between inhaled treprostinil and inhaled iloprost in severe pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 109s Year: 2004 Influence of inhaled iloprost on transpulmonary gradient of big-endothelin in patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002